The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery-Reference-Cited by-同舟云学术

The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery

Published:2015-07-23 Issue:12 Volume:32 Page:3927-3936
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Brill Margreke J.,van Rongen Anne,van Dongen Eric P.,van Ramshorst Bert,Hazebroek Eric J.,Darwich Adam S.,Rostami-Hodjegan Amin,Knibbe Catherijne A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s11095-015-1752-9.pdf

Reference51 articles.

1. Shields M, Carroll MD, Ogden CL. Adult obesity prevalence in Canada and the United States. In: Services usdohah, editor. Hyattsville, MD: NCHS Data Brief; 2011.

2. IASO. International Association for the Study of Obesity. In: IASO.

3. Hautvast J. Overgewicht en obesitas. In: Health Council of the Netherlands; 2003.

4. Craig RMJ, et al. Cardiovascular disease and risk factors in adults. London: The Information Centre for Health and Social Care. In: Health Survey for England 2006; 2008.

5. Andreyeva T, Michaud PC, van Soest A. Obesity and health in Europeans aged 50 years and older. Public Health. 2007;121(7):497–509.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication and supplement pharmacokinetic changes following bariatric surgery: A systematic review and meta‐analysis;Obesity Reviews;2024-05-06

2. mRNA expression levels of cytochrome P450 CYP1A2 , CYP3A4 , and CYP3A5 in the epidermis: a focus on individual differences among Japanese individuals;Xenobiotica;2024-04-24

3. Impact of bariatric surgery on cytochrome P 450 enzyme activity;Frontiers in Pharmacology;2024-03-25

4. Chirurgie bariatrique et médicaments : revue de la littérature et analyse des effets indésirables dans la banque nationale de pharmacovigilance;Therapies;2024-02

5. Overnight 1-mg Dexamethasone Suppression Test for Screening Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS): What Happens when Serum Dexamethasone Is Below Cutoff? How Frequent Is it?;Endocrine Practice;2023-12